Search
for
Sort by
Research 391–420 of 1000+
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Novel drugs of United States Food and Drug Administration approved in 2024
- FGF Family: From Drug Development to Clinical Application
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
- Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol
- Potassium channel openers: therapeutic potential in cardiology and medicine
- Multi-functional engineered polypeptide-based drug delivery systems for improved cancer therapy
- Mesalazine in the treatment of extensive alopecia areata: A new therapeutic option?
- The pattern of off-label and unlicensed drug use in adult and pediatric patients in the Kingdom of Saudi Arabia: multicenter retrospective study
- INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Human serum albumin nanoparticles for enhanced drug delivery to treat breast cancer: Preparation and In Vitro assessment
- Combining rapid degrading microneedles with Slow-Released drug delivery system for the treatment of alopecia areata
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- GBP1 as a machine learning-prioritized biomarker and therapeutic target for epstein-barr virus-induced clear cell renal cell carcinoma: multi-omics causal validation
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Recent Insights into the Potential and Challenges of Sericin as a Drug Delivery Platform for Multiple Biomedical Applications
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review
- Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against Diabetes
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Advances in histamine-mediated allergy management: Expanding perspectives on cetirizine’s therapeutic, safety, and toxicological implications
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- Progress on mitochondria and hair follicle development in androgenetic alopecia: relationships and therapeutic perspectives
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- A review for cell-based screening methods in drug discovery